RxDoctor Payments Data

David Burnikel, MD

Orthopaedic Surgery · San Diego, CANPI 1457541369

Payments from drug & device makers

$11,166in general payments, 2019–2025

Across 90 payments — averaging $124.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$5K
  • Elevate Surgical Co$1K
  • Impactortho, Inc.$1K
  • Stryker$1K
  • Sportstek Medical, Inc$919
  • Johnson & Johnson$380
  • plus $1K from 15 others

What the payments were for

  • Travel & lodging$1,79416%
  • Food & beverage$4,07937%
  • Education$5,29347%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arthrex34$5,248
Elevate Surgical Co7$1,299
Impactortho, Inc.2$1,225
Stryker13$1,049
Sportstek Medical, Inc2$919
Johnson & Johnson(2 entities)12$380
Smith+Nephew4$164
Acumed LLC1$144
BREG, Inc1$123
Pacira Pharmaceuticals Incorporated1$122
Catalyst Orthoscience1$101
Linvatec Corporation1$97
Molnlycke Health Care US, LLC1$75
Sanofi-aventis U.S. LLC3$58
Electronic Waveform Lab, Inc.1$36
Fidia Pharma USA Inc.1$26
Pacira Therapeutics, Inc.1$25
Vericel Corporation1$21
DJO, LLC1$20
Ferring Pharmaceuticals Inc.1$19
Medtronic1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,166 in reported general payments places this provider in the 70th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California

Medicare billing

Part B allowed, 2024
$74,428
Medicare patients
129
Services billed
995

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron OdtOndansetron13$167
Oxycodone Hcl31$152
Meloxicam34$92

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →